Patents by Inventor Peter Mombaerts

Peter Mombaerts has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090126032
    Abstract: A nuclear transfer method is provided wherein nuclear DNA in whole or part is injected into enucleated oocytes. The method is suitable for different donor cells, and preferably ES cells.
    Type: Application
    Filed: July 29, 2008
    Publication date: May 14, 2009
    Inventors: Anthony C.F. Perry, Peter Mombaerts, Teruhiko Wakayama
  • Publication number: 20030213008
    Abstract: A nuclear transfer method is provided wherein nuclear DNA in whole or part is injected into enucleated oocytes. The method is suitable for different donor cells, and preferably ES cells.
    Type: Application
    Filed: October 16, 2002
    Publication date: November 13, 2003
    Inventors: Anthony C.F. Perry, Peter Mombaerts, Teruhiko Wakayama
  • Publication number: 20030036195
    Abstract: The present invention provides methods of preparing mammalian cells and tissues for therapeutic and diagnostic purposes that are derived from ntES cells. The present invention further provides the mammalian cells and tissues themselves. In addition, methods of using the mammalian cells and tissues as a therapeutic agent or as a diagnostic are provided.
    Type: Application
    Filed: April 22, 2002
    Publication date: February 20, 2003
    Inventors: Lorenz Studer, Viviane Tabar, Peter Mombaerts, Teruhiko Wakayama, Anthony Perry
  • Patent number: 5859307
    Abstract: Immunodeficient animals are generated by introducing a mutation in RAG-1 into the germline of the animals via gene targeting in embryonic stem cells. The production of mutant RAG-1 deficient mice is detailed. RAG-1 deficient mice have no mature B and T lymphocytes. The arrest of B and T cell differentiation occurs at an early stage and correlates with the inability to perform V(D)J recombination. To date, these mice do not have mature B and T lymphocytes, nor do they express immunoglobulin or T cell receptors. The same strategy can be applied to the generation of other RAG-1 deficient animals, such as rabbits, rats, and pigs, using known techniques. These animals are all useful for the same general purposes as the scid mice, for example, cultivation of human lymphocytes for expression of human immunoglobulin.
    Type: Grant
    Filed: June 7, 1994
    Date of Patent: January 12, 1999
    Assignees: Massachusetts Institute of Technology, Dana Farber Cancer Institute & Tufts University
    Inventors: Peter Mombaerts, Susumu Tonegawa, Randall S. Johnson, Virginia Papaioannou